VELUCOVACAP
UNII 54HU9J47SF

Substance Identification & Data

This profile provides standardized clinical and technical data for Velucovacap, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 54HU9J47SF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2856375-51-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

54HU9J47SF

CAS Registry Number

2856375-51-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VELUCOVACAP

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203084

National Cancer Institute reference terminology for clinical and research data.

INN ID

13039

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Velucovacap

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Velucovacap. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Velucovacap

Common Names & Synonyms

Fibronectin-binding protein (recombinant Streptococcus dysgalactiae catcher moiety-containing) fusion protein with peptide linker (GSGS) fusion protein with viral spike glycoprotein (severe acute respiratory syndrome coronavirus 2 receptor-binding domain) fusion protein with peptide (synthetic linker-C-tag), henhexacontamer, (9′→32)-amide with peptide [9-aspartic acid] (synthetic split protein tag) fusion protein with linker (GSGTAGGGSGS) fusion protein with viral coat protein (bacteriophage AP205), octacontahectamer

N-L-glycyl-split protein tag peptide (2-15) fused via the peptide linker16GSGTAGGGSGS26 to Acinetobacter phage AP205 coat protein fragment (Met1 >del, 2-131, 27-156 in the current sequence), produced in Escherichia coli, conjugated via isopeptide bond (formed by the reaction between N9 and K32 with associated loss of one amino group) to N-L -glycyl-catcher peptide fragment (2-114) derived from Streptococcus dysgalactiae fibronectin binding protein fused via peptide linker 115GSGS118to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein (S glycoprotein) receptor binding domain (RBD) fragment (GenBank ID: QIA20044.1;306-578, 119-391 in the current sequence) fused via peptide linker 392GSGS395to a 396EPEA399C-terminal tag peptide, produced in Drosophila melanogaster S2 cells, glycoform alfa. The Acinetobacter phage AP205 coat protein-containing monomers self-assemble into a virus-like particle (VLP) consisting of 180 subunits of which approximately 61 surface exposed copies spontaneously conjugate with the RBD-containing recombinant fusion protein when mixed together

velucovacap [INN]

External Clinical & Regulatory Resources

Previous UNII54HM6O0YGK

Next UNII54HWN0SA3E